Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/43480
DC FieldValueLanguage
dc.contributor.authorRubio Sánchez, Saraen_US
dc.contributor.authorLeón, Franciscoen_US
dc.contributor.authorQuintana Aguiar, José Martínen_US
dc.contributor.authorCutler, Stephenen_US
dc.contributor.authorEstévez Rosas, Francisco Jesúsen_US
dc.contributor.otherQuintana, Jose-
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherRubio, Sara-
dc.contributor.otherRUBIO SANCHEZ, SARA-
dc.contributor.otherLeon, Francisco-
dc.date.accessioned2018-11-21T15:29:58Z-
dc.date.available2018-11-21T15:29:58Z-
dc.date.issued2012en_US
dc.identifier.issn0223-5234en_US
dc.identifier.urihttp://hdl.handle.net/10553/43480-
dc.description.abstractA new class of methyl esters of flavonoids, with different substituents on the B ring were synthesized and evaluated for their antiproliferative activity against the human leukemia cell line HL-60. The presence of either a methyl group (1f) or a chlorine atom (1o) at position 2' of the B ring played an important role in affecting antiproliferative activity. The cytotoxic effects of these compounds were accompanied by the concentration- and time-dependent appearance of DNA- and nuclear-fragmentation, increase in the percentage of sub-G(1) cells, and processing of multiple caspases and poly(ADP-ribose)polymerase cleavage. Pretreatment of cells with the specific mitogen-activated extracellular kinases (MEK) 1/2 inhibitor PD98059, together with 1f and 1o, resulted in an important enhancement of cell death, which might have clinical implications for the use of both compounds in combination with MEK 1/2 inhibitors as potential therapeutic agents.en_US
dc.languageengen_US
dc.publisher0223-5234-
dc.relationEvaluación de Potenciales Compuestos Antileucémicos.en_US
dc.relation.ispartofEuropean Journal of Medicinal Chemistryen_US
dc.sourceEuropean Journal of Medicinal Chemistry [ISSN 0223-5234], v. 55, p. 284-296en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherApoptosisen_US
dc.subject.otherCaspasesen_US
dc.subject.otherCell cycleen_US
dc.subject.otherCytotoxicityen_US
dc.titleCell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signalingen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ejmech.2012.07.028en_US
dc.identifier.scopus84865755962-
dc.identifier.isi000309494100030-
dcterms.isPartOfEuropean Journal Of Medicinal Chemistry-
dcterms.sourceEuropean Journal Of Medicinal Chemistry[ISSN 0223-5234],v. 55, p. 284-296-
dc.contributor.authorscopusid22635323400-
dc.contributor.authorscopusid7005039451-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid36183236500-
dc.contributor.authorscopusid7003810011-
dc.description.lastpage296en_US
dc.description.firstpage284en_US
dc.relation.volume55en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000309494100030-
dc.contributor.daisngid4276242-
dc.contributor.daisngid136703-
dc.contributor.daisngid128315-
dc.contributor.daisngid59825-
dc.contributor.daisngid384944-
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDK-4656-2013-
dc.identifier.investigatorRIDNo ID-
dc.identifier.investigatorRIDNo ID-
dc.contributor.wosstandardWOS:Rubio, S-
dc.contributor.wosstandardWOS:Leon, F-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Cutler, S-
dc.contributor.wosstandardWOS:Estevez, F-
dc.date.coverdateSeptiembre 2012en_US
dc.identifier.ulpgces
dc.description.sjr1,201
dc.description.jcr3,499
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-7633-1285-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRubio Sánchez, Sara-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

14
checked on Apr 21, 2024

WEB OF SCIENCETM
Citations

14
checked on Feb 25, 2024

Page view(s)

65
checked on Mar 23, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.